Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Fagerhol

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Birth Defects Original Article Series|January 1, 1974
Alpha-1-antitrypsin deficiency in pulmonary and liver degenerationM K Fagerhol
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1988
[AIDS testing on a large scale is needed in the fight against the epidemic]M K Fagerhol
Clinical Molecular Pathology|April 1, 1996
Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?M K Fagerhol
Lancet (London, England)|December 16, 2000
Calprotectin, a faecal marker of organic gastrointestinal abnormalityM K Fagerhol
Postgraduate Medical Journal|January 1, 1976
The genetics of alpha-1-antitrypsin and its implicationsM K Fagerhol
Le Poumon Et Le Coeur|January 1, 1971
[The Pi system, its genetics and its relations with diseases]M K Fagerhol
Molecular Pathology : MP|September 29, 2001
Calprotectin inhibits matrix metalloproteinases by sequestration of zincB Isaksen, M K Fagerhol
Scandinavian Journal of Haematology|January 1, 1974
Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VIIH Gjonnaess, M K Fagerhol
Scandinavian Journal of Respiratory Diseases|October 1, 1979
Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of OsloA Gulsvik, M K Fagerhol
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1972
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinaseH Arnesen, M K Fagerhol
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Birth Defects Original Article Series|January 1, 1974
Alpha-1-antitrypsin deficiency in pulmonary and liver degenerationM K Fagerhol
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1988
[AIDS testing on a large scale is needed in the fight against the epidemic]M K Fagerhol
Clinical Molecular Pathology|April 1, 1996
Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?M K Fagerhol
Lancet (London, England)|December 16, 2000
Calprotectin, a faecal marker of organic gastrointestinal abnormalityM K Fagerhol
Postgraduate Medical Journal|January 1, 1976
The genetics of alpha-1-antitrypsin and its implicationsM K Fagerhol
Le Poumon Et Le Coeur|January 1, 1971
[The Pi system, its genetics and its relations with diseases]M K Fagerhol
Molecular Pathology : MP|September 29, 2001
Calprotectin inhibits matrix metalloproteinases by sequestration of zincB Isaksen, M K Fagerhol
Scandinavian Journal of Haematology|January 1, 1974
Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VIIH Gjonnaess, M K Fagerhol
Scandinavian Journal of Respiratory Diseases|October 1, 1979
Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of OsloA Gulsvik, M K Fagerhol
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1972
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinaseH Arnesen, M K Fagerhol
Pageof 12